General Information
Product name
m-Toluidine
CAS No.
108-44-1
1.2.1 Relevant identified uses
Laboratory chemicals, Industrial & for professional use only
Emergency telephone
+91 99921 51495
Icons in SDS
Company Information
company name
Bio-Chem Chemicals
e-mail address of the competent person responsible for the Safety Data Sheet
info@biofinechemical.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301+H311+H331, H319, H373, H410
Hazard statements
Code
Statements
H301+H311+H331
Toxic if swallowed, in contact with skin or if inhaled
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008] Classification of the substance or mixture
Signal word
Danger
Hazard statements
H301 + H311 + H331 Toxic if swallowed, in contact with skin or if inhaled H319 Causes serious eye irritation. H373 May cause damage to organs through prolonged or repeated exposure. H410 Very toxic to aquatic life with long lasting effects.
Precautionary statements
P261 Avoid breathing vapours. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing. P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER/doctor. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P311 Call a POISON CENTER /doctor.
Supplemental label elements
none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Acute toxicity, Oral (Category 3), H301 Acute toxicity, Inhalation (Category 3), H331 Acute toxicity, Dermal (Category 3), H311 Eye irritation (Category 2), H319 Specific target organ toxicity - repeated exposure (Category 2), H373 Acute aquatic toxicity (Category 1), H400 Chronic aquatic toxicity (Category 1), H410 For the full text of the H-Statements mentioned in this Section, see Section 16.
